NCT02145169View on ClinicalTrials.gov

Inhaled Nitrous Oxide for the Prevention of Emergence Reaction During Ketamine Administration in Adults, a Pilot Study

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Emergence ReactionProcedural Sedation
Interventions
DRUG

Inhaled Nitrous Oxide

Patients undergoing procedural sedation with Ketamine will receive inhaled Nitrous Oxide

Trial Locations (1)

19141

Albert Einstein Healthcare Network, Philadelphia

All Listed Sponsors
lead

Albert Einstein Healthcare Network

OTHER

NCT02145169 - Inhaled Nitrous Oxide for the Prevention of Emergence Reaction During Ketamine Administration in Adults, a Pilot Study | Biotech Hunter | Biotech Hunter